WallStreetZenWallStreetZen

NASDAQ: CTKB
Cytek Biosciences Inc Stock Ownership - Who owns Cytek Biosciences?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Cytek Biosciences Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Ming YanCHIEF TECHNOLOGY OFFICER2024-04-1920,000$5.87
$117.40kSell
Ming YanCHIEF TECHNOLOGY OFFICER2024-04-091,500$7.00
$10.50kSell
Ming YanCHIEF TECHNOLOGY OFFICER2024-04-09400$7.01
$2.80kSell
Philippe BusqueSVP GLOBAL SALES AND SERVICES2024-03-202,129$6.70
$14.26kSell
Ming YanCHIEF TECHNOLOGY OFFICER2024-03-1920,000$6.71
$134.20kSell
Ming YanCHIEF TECHNOLOGY OFFICER2024-03-1820,000$6.77
$135.40kSell
Allen PoirsonSVP BUS. AND CORP. DEV.2024-03-111,301$7.22
$9.39kSell
Valerie BarnettCHIEF LEGAL OFFICER2024-03-111,912$7.22
$13.80kSell
Patrik JeanmonodCHIEF FINANCIAL OFFICER2024-03-111,912$7.22
$13.80kSell
Wenbin JiangPRESIDENT AND CEO2024-03-114,646$7.22
$33.54kSell

1 of 8

CTKB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CTKB insiders and whales buy or sell their stock.

CTKB Shareholders

What type of owners hold Cytek Biosciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc13.59%17,779,753$100.63MInstitution
Ra Capital Management LP10.23%13,381,054$75.74MInsider
Brown Capital Management LLC9.19%12,016,325$68.01MInstitution
Vanguard Group Inc9.09%11,890,700$67.30MInstitution
Wenbin Jiang6.09%7,970,511$45.11MInsider
Ra Capital Management LP5.21%6,809,404$38.54MInstitution
Hhlr Advisors Ltd5.09%6,657,030$37.68MInstitution
Ming Yan4.58%5,988,502$33.89MInsider
State Street Corp3.06%3,997,769$22.63MInstitution
New York State Common Retirement Fund2.25%2,947,986$16.69MInstitution

1 of 3

CTKB vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CTKB60.34%21.49%Net SellingNet Selling
FNA17.89%82.11%Net SellingNet Buying
KIDS43.14%56.86%Net SellingNet Selling
SILK83.32%16.68%Net SellingNet Selling
VREX98.75%1.25%Net SellingNet Selling
View Top Medical Device Stocks

Cytek Biosciences Stock Ownership FAQ

Who owns Cytek Biosciences?

Cytek Biosciences (NASDAQ: CTKB) is owned by 60.34% institutional shareholders, 21.49% Cytek Biosciences insiders, and 18.17% retail investors. Ra Capital Management LP is the largest individual Cytek Biosciences shareholder, owning 13.38M shares representing 10.23% of the company. Ra Capital Management LP's Cytek Biosciences shares are currently valued at $75.34M.

If you're new to stock investing, here's how to buy Cytek Biosciences stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.